Aurobindo Eyes Opportunities After Offloading Natrol For $550m

US-Based Nutritionals Firm To Be Sold After Six Years

 
• By Dean Rudge

Aurobindo has agreed to sell its US-based Natrol dietary supplements business at a significant premium to the $132.5m it paid in late 2014, as the Indian firm continues to drive into complex formulations in the US, including injectables and biosimilars.

TrayOfMoney
Aurobindo may eye further M&A with the cash derived from the sale of Natrol. • Source: Shutterstock

Aurobindo has pledged to pay down debt and invest in “new strategic initiatives,” after agreeing to divest the company’s US-based Natrol dietary supplements business for approximately $550m in cash.

The transaction, offloading Natrol to an affiliate of US-based private equity New Mountain Capital, is scheduled to close to close by January 2021, subject to

More from Deals

More from Business